Icosapent ethyl associated with plaque regression
Small trial shows regression of several plaque components, authors report
AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.
Taking icosapent ethyl daily in addition to a statin and following a low cholesterol diet may lead to regression of atherosclerotic plaque, a small trial shows.